Using AI to Fight Antibiotic-Resistant Bacteria
利用人工智慧對抗抗生素抗藥性細菌
更新於: 2026年6月26日 上午10:30
Antibiotic resistance is a growing global threat often called the silent pandemic.
抗生素耐藥性是一項日益嚴重的全球性威脅，常被稱為「隱形大流行」。
Traditional drug development is slow and unpredictable, but artificial intelligence is changing the game.
傳統的藥物研發既緩慢又不可預測，但人工智慧(AI)正在改變這一局面。
By using machine learning, researchers can scan millions of chemical compounds in days, a process that used to take years.
透過使用機器學習，研究人員可以在幾天內篩選數百萬種化合物，而這一過程過去需要耗費數年。
AI is not just screening existing drugs; generative models can now design entirely new molecules that evolution has never created, helping to bypass bacterial resistance.
AI不僅僅是在篩選現有的藥物；生成式模型現在還能設計出進化從未產生過的全新分子，有助於繞過細菌的抗藥性。
Beyond drug discovery, AI improves diagnostics by identifying antibiotic susceptibility in hours instead of days.
除了藥物研發之外，AI還能透過在數小時內識別抗生素的敏感性來改善診斷。
This shift allows doctors to prescribe targeted treatments much faster.
這種轉變使醫生能更快地開出針對性的治療方案。
